Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

Innovative ‘Poop Pills’ Dramatically Improve Cancer Treatment

By HospiMedica International staff writers
Posted on 04 Feb 2026

Immunotherapy has transformed cancer care, but many patients either fail to respond or develop severe side effects that force treatment to stop early. More...

In kidney cancer, lung cancer, and melanoma, immune-related complications such as colitis and diarrhea can significantly reduce quality of life and limit survival benefits. At the same time, response rates to immunotherapy remain inconsistent across cancer types. New clinical studies now show that modifying the gut microbiome can both reduce treatment toxicity and substantially improve patient response to immunotherapy.

In research led by Lawson Research Institute (Ontario, Canada), in collaboration with London Health Sciences Centre Research Institute (LHSCRI, Ontario, Canada) and clinical partners, scientists have developed advanced oral fecal microbiota transplant capsules, known as LND101, created from healthy donor stool and designed to restore a balanced gut microbiome safely. The capsules are standardized, scalable, and easy to administer, making them suitable for use alongside cancer immunotherapy in clinical settings.

In a Phase I clinical trial, researchers evaluated whether FMT could be safely combined with immunotherapy in patients with advanced kidney cancer. The study involved 20 patients treated at a specialized cancer center and focused on reducing immune-related side effects that often limit therapy. The findings, published in Nature Medicine, showed that customized FMT could significantly reduce gastrointestinal toxicity without compromising cancer treatment.

Separate Phase II trials examined the effect of FMT on immunotherapy response in lung cancer and melanoma. In lung cancer patients, 80 percent responded to immunotherapy after receiving FMT, compared with the typical 39–45 percent response rate seen with immunotherapy alone. In melanoma, 75 percent of patients responded following FMT, compared with about 50–58 percent in standard treatment, demonstrating a marked improvement across both cancer types.

Together, the studies suggest that fecal microbiota transplantation can both enhance immunotherapy effectiveness and reduce harmful side effects, addressing two major limitations of current cancer treatments. By reshaping the gut microbiome, FMT appears to remove harmful bacteria and promote immune responses that better target tumors. Researchers are now expanding this approach through larger randomized trials, including pan-Canadian studies, and exploring its potential in other cancers such as pancreatic and triple-negative breast cancer.

“Our clinical trials show that fecal microbiota transplantation can both reduce immunotherapy toxicity and significantly improve treatment response,” said Dr. Arielle Elkrief, Physician Scientist and Co-Principal Investigator, who was involved in the lung cancer and melanoma studies. “These results open a new path toward personalized microbiome-based therapies in oncology.”

Related Links:
Lawson Research Institute
LHSCRI


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Glucose Meter
StatStrip®
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Design-science framework integrating CML and LLM pipelines for supply chain risk evaluation. (Gupta I, Konduru H, Correa S, et al. A causal analytics approach for interpretable supply chain risk and supplier performance evaluation. Supply Chain Analytics, 2026. doi:10.1016/j.sca.2026.100248)

Causal AI Tool Withholds Ovarian Cancer Treatment Recommendations When Evidence Insufficient

Ovarian cancer treatment often requires individualized decisions, particularly when available patient data do not clearly favor one therapeutic approach. However, artificial intelligence (AI) systems may... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image: Overview of the study design, including participant recruitment, multimodal neuroimaging analysis, stage- and cognition-informed feature selection, and development and validation of the DBFG-Net model. CKD-CI, CKD with cognitive impairment; CKD-NCI, CKD without cognitive impairment; HCs, healthy controls; CBF, cerebral blood flow; DBFG-Net, Dual-Branch Feature-Gated Network. (Photo courtesy of Wenbo Yang and Lijun Song, Capital Medical University)

AI Combines Brain Imaging Features to Identify Cognitive Impairment in CKD

Chronic kidney disease (CKD) can affect multiple organs, including the brain, with cognitive impairment emerging as a common complication. Changes in executive function, attention, and memory can reduce... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.